Your session is about to expire
← Back to Search
Aortic aneurysm for Aortic Dissection (THOR Trial)
N/A
Waitlist Available
Led By Malakh Shrestha, Prof. Dr.
Research Sponsored by Vascutek Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year post-procedure
Awards & highlights
No Placebo-Only Group
Summary
This is a global, prospective non-interventional, multi-centre, post-market study of the Vascutek Thoraflex™ Hybrid system in patients with acute thoracic aortic syndrome, subacute/chronic dissection of the aorta and aortic aneurysm.
Eligible Conditions
- Aortic Dissection
- Thoracoabdominal Aortic Aneurysm
- Dissecting Aneurysm
- Aortic Rupture
- Aortic Ulcers
- Thoracic Aortic Aneurysm
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year post-procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year post-procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Freedom from Major Adverse Event
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Subacute/chronic dissection of the aortaExperimental Treatment1 Intervention
60 patients, standard of care (non-interventional) EQ-5D-5L QOL Questionnaire
Group II: Aortic aneurysmExperimental Treatment1 Intervention
60 patients, standard of care (non-interventional) EQ-5D-5L QOL Questionnaire
Group III: Acute thoracic aortic syndromeExperimental Treatment1 Intervention
60 patients, standard of care (non-interventional) EQ-5D-5L QOL Questionnaire
Find a Location
Who is running the clinical trial?
Vascutek Ltd.Lead Sponsor
16 Previous Clinical Trials
5,563 Total Patients Enrolled
4 Trials studying Aortic Dissection
858 Patients Enrolled for Aortic Dissection
Malakh Shrestha, Prof. Dr.Principal InvestigatorHannover Medical School
Share this study with friends
Copy Link
Messenger